KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Receivables (2020 - 2025)

Historic Receivables for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $1.5 billion.

  • Organon's Receivables fell 1192.88% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year decrease of 1192.88%. This contributed to the annual value of $1.4 billion for FY2024, which is 2213.3% down from last year.
  • Organon's Receivables amounted to $1.5 billion in Q3 2025, which was down 1192.88% from $1.5 billion recorded in Q2 2025.
  • Over the past 5 years, Organon's Receivables peaked at $2.5 billion during Q2 2021, and registered a low of $1.0 billion during Q1 2021.
  • Its 5-year average for Receivables is $1.7 billion, with a median of $1.7 billion in 2022.
  • Examining YoY changes over the last 5 years, Organon's Receivables showed a top increase of 6633.66% in 2022 and a maximum decrease of 2321.72% in 2022.
  • Organon's Receivables (Quarter) stood at $1.8 billion in 2021, then grew by 3.59% to $1.8 billion in 2022, then fell by 5.68% to $1.7 billion in 2023, then dropped by 22.13% to $1.4 billion in 2024, then rose by 9.28% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.5 billion for Q2 2025, and $1.5 billion during Q1 2025.